Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO Transcript
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO - Slideshow (NASDAQ:CRBP) 2026-05-26
Corbus offre un potentiel de hausse malgré la mise à jour post-FDA, l'analyste souligne un avantage concurrentiel | Benzinga France